Correlation Between Arrowhead Pharmaceuticals and AMG Advanced

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Arrowhead Pharmaceuticals and AMG Advanced at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arrowhead Pharmaceuticals and AMG Advanced into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arrowhead Pharmaceuticals Corp and AMG Advanced Metallurgical, you can compare the effects of market volatilities on Arrowhead Pharmaceuticals and AMG Advanced and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arrowhead Pharmaceuticals with a short position of AMG Advanced. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arrowhead Pharmaceuticals and AMG Advanced.

Diversification Opportunities for Arrowhead Pharmaceuticals and AMG Advanced

-0.62
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Arrowhead and AMG is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Arrowhead Pharmaceuticals Corp and AMG Advanced Metallurgical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AMG Advanced Metallu and Arrowhead Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arrowhead Pharmaceuticals Corp are associated (or correlated) with AMG Advanced. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AMG Advanced Metallu has no effect on the direction of Arrowhead Pharmaceuticals i.e., Arrowhead Pharmaceuticals and AMG Advanced go up and down completely randomly.

Pair Corralation between Arrowhead Pharmaceuticals and AMG Advanced

Assuming the 90 days trading horizon Arrowhead Pharmaceuticals Corp is expected to generate 2.89 times more return on investment than AMG Advanced. However, Arrowhead Pharmaceuticals is 2.89 times more volatile than AMG Advanced Metallurgical. It trades about 0.24 of its potential returns per unit of risk. AMG Advanced Metallurgical is currently generating about -0.11 per unit of risk. If you would invest  2,013  in Arrowhead Pharmaceuticals Corp on September 5, 2024 and sell it today you would earn a total of  651.00  from holding Arrowhead Pharmaceuticals Corp or generate 32.34% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy95.65%
ValuesDaily Returns

Arrowhead Pharmaceuticals Corp  vs.  AMG Advanced Metallurgical

 Performance 
       Timeline  
Arrowhead Pharmaceuticals 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Arrowhead Pharmaceuticals Corp are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Arrowhead Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
AMG Advanced Metallu 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in AMG Advanced Metallurgical are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, AMG Advanced is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Arrowhead Pharmaceuticals and AMG Advanced Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Arrowhead Pharmaceuticals and AMG Advanced

The main advantage of trading using opposite Arrowhead Pharmaceuticals and AMG Advanced positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arrowhead Pharmaceuticals position performs unexpectedly, AMG Advanced can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AMG Advanced will offset losses from the drop in AMG Advanced's long position.
The idea behind Arrowhead Pharmaceuticals Corp and AMG Advanced Metallurgical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance